overall sales volume, the Company and its subsidiaries brought 1.6% growth of Gross profit margin versus 2017 by the strong contribution of Epicerol® business. 2. In 2018, distribution costs, administrative

of income from investment in associate 0.25 0.40 -0.15 -37.5% Corporate Income tax expenses -14.83 -11.74 -3.09 26.3% Net profit for the period 59.32 47.10 12.22 25.9% Profit Sharing for non

clarifies the performance as follows: During the second quarter of 2020, the Company had the total revenue and share of profit and net profit of THB 1,966.7 mm and THB 542.1 mm, respectively. If excluding FX

from THB 225.0 Mn to THB 300.0 in preparation for the initial public offering (2) payment of shareholder dividend of THB 101.3 Mn and (3) net profit of the company during the period of THB 32.1 Mn. Cash

subsidiaries by having the main substance is as follows. (Unit: Thousand Baht) Revenues Gross Profit Selling Admin Net profit 2017 837,308 293,207 80,159 93,260 -236,013 2018 929,354 325,527 88,001 79,800

Baht) Q3/2017 Q3/2016 Change Revenue 186 227 (41) Gross profit margin 62 89 (27) Selling Expenses 17 28 (11) Administrative Expenses 18 19 (1) Finance cost 5 5 - Net profit 19 28 (9) In overall, the

2017 ended December 31, 2017 of the Company and its subsidiaries, as shown below : (Unit : Million Baht) 2017 2016 Change Revenue 837 849 -1.4% Gross profit margin 293 342 -16.7% Selling Expenses 80 96

December 31, 2017, the Company and its subsidiaries had total shareholder equity of 262 MB, decreased from December 31, 2016 in amount of 230 MB due to the Company and its subsidiaries' net profit for year

Gross Profit Selling Admin Net(loss) profit Q1/17 212,140 78,137 19,861 24,659 21,584 Q1/18 213,552 76,707 21,974 18,709 27,898 % Change 0.67 (1.83) 10.64 (24.13) 29.25 In overall, the Company and its

, the Company and its subsidiaries had total shareholder equity of 358.5 MB, increased from December 31, 2017 at 96.4 MB due to the Company and its subsidiaries had net profit for Q3/2018 at 96.4 MB